Sarissa Capital Management as of Sept. 30, 2017
Portfolio Holdings for Sarissa Capital Management
Sarissa Capital Management holds 9 positions in its portfolio as reported in the September 2017 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Biogen Idec (BIIB) | 37.1 | $120M | 384k | 313.12 | |
| Bioverativ | 20.5 | $67M | 1.2M | 57.07 | |
| Medicines Company | 20.0 | $65M | 1.8M | 37.04 | |
| Innoviva (INVA) | 15.7 | $51M | 3.6M | 14.12 | |
| Achillion Pharmaceuticals | 3.0 | $9.6M | 2.1M | 4.49 | |
| Noveliontherapeuti.. | 2.2 | $7.2M | 1.0M | 7.03 | |
| Apricus Biosciences | 0.8 | $2.5M | 1.4M | 1.71 | |
| Advaxis | 0.4 | $1.4M | 339k | 4.18 | |
| Abbvie (ABBV) | 0.3 | $888k | 10k | 88.80 |
